Ali Can Kurtipek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Can Kurtipek has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Selma Karaahmetoğlu
Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara, Turkey
5 shared publications - Emra Asfuroğlu Kalkan
Department of Internal Medicine, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye
3 shared publications - Ihsan Ates
Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara 06800, Türkiye
3 shared publications - Oğuz Öztürk
Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Türkiye
3 shared publications - Oğuzhan Zengin
Department of Internal Medicine, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye
3 shared publications - Andaç Uzdoğan
Department of Biochemistry, Ankara Bilkent City Hospital, Ankara, Turkey
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Galenos Yayinevi in Gazi Medical Journal
Persistent or Exacerbated Lymphopenia Predicts Mortality in Kidney Transplant Recipients Hospitalized with COVID-19
Persistent or Exacerbated Lymphopenia Predicts Mortality in Kidney Transplant Recipients Hospitalized with COVID-19 - Gazi Medical Journal
- 15 October 2026
- Published by Galenos Yayinevi in Gazi Medical Journal
Open AccessPersistent or Exacerbated Lymphopenia Predicts Mortality in Kidney Transplant Recipients Hospitalized with COVID-19
Persistent or Exacerbated Lymphopenia Predicts Mortality in Kidney Transplant Recipients Hospitalized with COVID-19 - Gazi Medical Journal
- 16 September 2026
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 7 (3) , 718-724
A Comparative Analysis of Inpatient Versus Outpatient Management for Severely Uncontrolled Type 2 Diabetes
Background: The global burden of diabetes continues to rise, driven by increasing prevalence, high complication rates, and substantial healthcare costs. While hospitalization is essential for acute metabolic emergencies, a considerable “grey zone” population presents with severe hyperglycemia without overt crisis, for whom the optimal care setting remains uncertain. We aimed to evaluate the clinical rationale and system-level implications of inpatient versus intensive outpatient management strategies in patients with uncontrolled diabetes.Methods: In this retrospective, single-center study, we included all adult patients for a duration of 1 year with uncontrolled diabetes who met the hospitalization criteria as recommended by clinical guidelines and personalized clinical decision-making. The patients were grouped based on whether they accepted or refused hospitalization. Both groups were treated according to the most recent guidelines, and the outcomes after six-month follow-up of admitted patients were compared to those who were treated in an outpatient setting.Results: Patients were divided into outpatient (n=72) and inpatient (n=37) groups. Groups were comparable in terms of age, gender, and comorbidities with the exception of diabetic neuropathy, which was more prevalent among inpatients. Neither the percent reduction nor the absolute difference in HbA1c levels over the follow-up period differed significantly between groups. Conclusion: In our cohort of patients with uncontrolled diabetes, there was no statistical difference in outcomes between outpatient and inpatient groups. Given the lack of added benefit from inpatient care, future strategies should focus on optimizing outpatient monitoring and intervention programs to enhance adherence and achieve better long-term glycemic control.
- 16 September 2026
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 7 (3) , 718-724
A Comparative Analysis of Inpatient Versus Outpatient Management for Severely Uncontrolled Type 2 Diabetes
Background: The global burden of diabetes continues to rise, driven by increasing prevalence, high complication rates, and substantial healthcare costs. While hospitalization is essential for acute metabolic emergencies, a considerable “grey zone” population presents with severe hyperglycemia without overt crisis, for whom the optimal care setting remains uncertain. We aimed to evaluate the clinical rationale and system-level implications of inpatient versus intensive outpatient management strategies in patients with uncontrolled diabetes.Methods: In this retrospective, single-center study, we included all adult patients for a duration of 1 year with uncontrolled diabetes who met the hospitalization criteria as recommended by clinical guidelines and personalized clinical decision-making. The patients were grouped based on whether they accepted or refused hospitalization. Both groups were treated according to the most recent guidelines, and the outcomes after six-month follow-up of admitted patients were compared to those who were treated in an outpatient setting.Results: Patients were divided into outpatient (n=72) and inpatient (n=37) groups. Groups were comparable in terms of age, gender, and comorbidities with the exception of diabetic neuropathy, which was more prevalent among inpatients. Neither the percent reduction nor the absolute difference in HbA1c levels over the follow-up period differed significantly between groups. Conclusion: In our cohort of patients with uncontrolled diabetes, there was no statistical difference in outcomes between outpatient and inpatient groups. Given the lack of added benefit from inpatient care, future strategies should focus on optimizing outpatient monitoring and intervention programs to enhance adherence and achieve better long-term glycemic control.
- Open Access
Relationship of Renal Sinus Fat and Circadian Blood Pressure in Patients with Hepatosteatosis: A New Perspective from a Retrospective Study
Background and Objectives: Renal sinus fat accumulation affects many diabetic processes, including blood pressure. The aim of this study was to find out if there is a link between the amount of fat in the renal sinus and the blood pressure that changes throughout the day in adults with non-alcoholic fatty liver disease (NAFLD). Materials and Methods: This retrospective analysis involved 55 adult patients diagnosed with non-alcoholic fatty liver disease (NAFLD) based on abdominal computed tomography (CT) and who had undergone 24 h ambulatory blood pressure monitoring (ABPM). According to standard ABPM criteria, individuals whose night-time systolic blood pressure decreased by ≥10% compared to daytime values were classified as “dippers,” whereas those with a reduction of Results: The non-dipper group had a significantly higher leukocyte count (p = 0.012). Renal sinus fat volume (RSFV) was significantly larger in the non-dipper group (6.41 ± 3 mL) than the dipper group (4.12 ± 2.26 mL; p = 0.005). In the ROC curve analysis showing the role of RSFV in predicting the non-dipper blood pressure pattern, the threshold value for RSFV in our cohort was determined as ≥3.7 mL with a positive predictive value of 72.2%. Conclusions: Our findings indicated that RSFV plays a significant role in predicting the non-dipper blood pressure profile among individuals diagnosed with NAFLD. Participants with an RSFV of 3.7 mL or more in our cohort were more likely to exhibit a non-dipping blood pressure pattern. Future studies are needed to validate these findings in larger cohorts.
Open AccessRelationship of Renal Sinus Fat and Circadian Blood Pressure in Patients with Hepatosteatosis: A New Perspective from a Retrospective Study
Background and Objectives: Renal sinus fat accumulation affects many diabetic processes, including blood pressure. The aim of this study was to find out if there is a link between the amount of fat in the renal sinus and the blood pressure that changes throughout the day in adults with non-alcoholic fatty liver disease (NAFLD). Materials and Methods: This retrospective analysis involved 55 adult patients diagnosed with non-alcoholic fatty liver disease (NAFLD) based on abdominal computed tomography (CT) and who had undergone 24 h ambulatory blood pressure monitoring (ABPM). According to standard ABPM criteria, individuals whose night-time systolic blood pressure decreased by ≥10% compared to daytime values were classified as “dippers,” whereas those with a reduction of Results: The non-dipper group had a significantly higher leukocyte count (p = 0.012). Renal sinus fat volume (RSFV) was significantly larger in the non-dipper group (6.41 ± 3 mL) than the dipper group (4.12 ± 2.26 mL; p = 0.005). In the ROC curve analysis showing the role of RSFV in predicting the non-dipper blood pressure pattern, the threshold value for RSFV in our cohort was determined as ≥3.7 mL with a positive predictive value of 72.2%. Conclusions: Our findings indicated that RSFV plays a significant role in predicting the non-dipper blood pressure profile among individuals diagnosed with NAFLD. Participants with an RSFV of 3.7 mL or more in our cohort were more likely to exhibit a non-dipping blood pressure pattern. Future studies are needed to validate these findings in larger cohorts.
- 2 January 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (1) , 63-70
Association between Hashimoto’s thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort study
Hashimoto's thyroiditis (HT) is a T-cell mediated autoimmune disease characterized by the progressive destruction of thyroid gland. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score and systemic inflammatory index (SII) are novel markers of inflammation. We aimed to compare HALP score and SII values of patients with HT to those in healthy control subjects in the present study. Patients diagnosed with HT and healthy volunteers (as controls) were included in the study. The SII and HALP score were calculated using the following formulas: SII = (Platelet count×Neutrophil count)/Lymphocyte count. HALP score = (Hemoglobin×Serum Albumin×Lymphocyte count)/Platelet count. SII and HALP score of patients with HT and healthy controls were compared. Median SII of the patients with HT (510 (140-3646)) was significantly higher than that of the control subjects (422 (102-2173)) (p < 0.001). Median HALP score of the HT group (47 (7-149)) was significantly lower than that of the control group (54 (10-160)) (p < 0.001). The sensitivity and specificity of SII (when higher than 452%) in detecting HT were 61% and 62%, respectively (AUC: 0.64, p < 0.001, 95%CI: 0.61-0.67). A HALP score lower than 49.5% threshold had 64% sensitivity and 57% specificity in detecting HT (AUC: 0.61, p < 0.001, 95%CI: 0.57-0.64). In logistic regression analysis (considering age, gender, eGFR, TSH, CRP, ESR, BMI), a unit increase in SII increased the risk of HT by 0.3% (p < 0.001, OR: 1.003, 95%CI: 1.002-1.004). HALP score was also an independent risk factor for HT. A unit increase in HALP score decreased the risk of HT by 2% (p < 0.001, OR: 0.977, 95%CI: 0.968-0.985). We recommend that, due to their inexpensive and easily assessable nature, SII and HALP score could serve as additional diagnostic tools in HT.
- 2 January 2026
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 138 (1) , 63-70
Association between Hashimoto’s thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort study
Hashimoto's thyroiditis (HT) is a T-cell mediated autoimmune disease characterized by the progressive destruction of thyroid gland. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score and systemic inflammatory index (SII) are novel markers of inflammation. We aimed to compare HALP score and SII values of patients with HT to those in healthy control subjects in the present study. Patients diagnosed with HT and healthy volunteers (as controls) were included in the study. The SII and HALP score were calculated using the following formulas: SII = (Platelet count×Neutrophil count)/Lymphocyte count. HALP score = (Hemoglobin×Serum Albumin×Lymphocyte count)/Platelet count. SII and HALP score of patients with HT and healthy controls were compared. Median SII of the patients with HT (510 (140-3646)) was significantly higher than that of the control subjects (422 (102-2173)) (p < 0.001). Median HALP score of the HT group (47 (7-149)) was significantly lower than that of the control group (54 (10-160)) (p < 0.001). The sensitivity and specificity of SII (when higher than 452%) in detecting HT were 61% and 62%, respectively (AUC: 0.64, p < 0.001, 95%CI: 0.61-0.67). A HALP score lower than 49.5% threshold had 64% sensitivity and 57% specificity in detecting HT (AUC: 0.61, p < 0.001, 95%CI: 0.57-0.64). In logistic regression analysis (considering age, gender, eGFR, TSH, CRP, ESR, BMI), a unit increase in SII increased the risk of HT by 0.3% (p < 0.001, OR: 1.003, 95%CI: 1.002-1.004). HALP score was also an independent risk factor for HT. A unit increase in HALP score decreased the risk of HT by 2% (p < 0.001, OR: 0.977, 95%CI: 0.968-0.985). We recommend that, due to their inexpensive and easily assessable nature, SII and HALP score could serve as additional diagnostic tools in HT.
- 28 November 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (5) , 3583-3593
Effectiveness of Boric Acid in Sepsis in Rats with Cecal Perforation
Introduction and Aim Sepsis is a systemic inflammatory response that develops in the host against microorganisms, which results in end-organ damage. Boric acid (BA) has been shown to have immune modulatory effects in vitro and in animal studies. The aim of the study is to investigate the effects of high dose BA on lung and kidney tissues in rats with sepsis induced by the CLP method. Method 28 rats were randomly divided into four groups: Group C (control group), Group BA, Group CLP (cecal ligation and puncture), and Group CLP + BA. Cecum was ligated below the ileocecal valve and punctured. BA was administered to the treatment groups at an intraperitoneal dose of 200 mg/kg, and at the end of 24 h, lung and kidney tissue samples were collected and evaluated for biochemical and histopathological parameters. Results Histopathologically, in kidney tissue, CLP + BA group showed significantly less peritubular capillary dilatation and brush border loss in the proximal tubule epithelium compared to the CLP group. In lung tissue, CLP + BA group had significantly less alveolar wall thickening compared to the CLP group. Biochemical analyses indicated that BA administration reduced oxidative stress in both renal and lung tissues. Conclusion We found that intraperitoneal administration of high dose boric acid partially ameliorated the tissue damage in rats subjected to CLP induced sepsis. Further studies are needed regarding the dosage and application at different time points.
- 28 November 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (5) , 3583-3593
Effectiveness of Boric Acid in Sepsis in Rats with Cecal Perforation
Introduction and Aim Sepsis is a systemic inflammatory response that develops in the host against microorganisms, which results in end-organ damage. Boric acid (BA) has been shown to have immune modulatory effects in vitro and in animal studies. The aim of the study is to investigate the effects of high dose BA on lung and kidney tissues in rats with sepsis induced by the CLP method. Method 28 rats were randomly divided into four groups: Group C (control group), Group BA, Group CLP (cecal ligation and puncture), and Group CLP + BA. Cecum was ligated below the ileocecal valve and punctured. BA was administered to the treatment groups at an intraperitoneal dose of 200 mg/kg, and at the end of 24 h, lung and kidney tissue samples were collected and evaluated for biochemical and histopathological parameters. Results Histopathologically, in kidney tissue, CLP + BA group showed significantly less peritubular capillary dilatation and brush border loss in the proximal tubule epithelium compared to the CLP group. In lung tissue, CLP + BA group had significantly less alveolar wall thickening compared to the CLP group. Biochemical analyses indicated that BA administration reduced oxidative stress in both renal and lung tissues. Conclusion We found that intraperitoneal administration of high dose boric acid partially ameliorated the tissue damage in rats subjected to CLP induced sepsis. Further studies are needed regarding the dosage and application at different time points.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 245-257
Post-ERCP Pancreatitis and Serum Asprosin: A Potential Marker Associated with Beta Cell Damage
Aim: Asprosin is a protein produced by adipose tissue that has a significant function in regulating glucose metabolism. Inflammation in pancreatitis leads to beta cell damage and deterioration of beta cell functions. Recent studies have shown a relationship between asprosin and pancreatic beta cell damage. This research aimed to examine the association between pancreatitis developing after endoscopic retrograde cholangiopancreatography (ERCP) and asprosin levels, which is also considered an indicator of beta cell damage. Materials and Methods: The study was conducted with 25 patients who developed pancreatitis after ERCP and 21 participants as a control group at Ankara Bilkent City Hospital. Acute pancreatitis was diagnosed through correlation of clinical, imaging, and laboratory findings. In addition, the post-ERCP pancreatitis group was classified as “mild” and “moderate-severe” according to disease severity, and asprosin levels were compared between the groups. Correlations between asprosin and biochemical and hematological parameters were analyzed. Results: Serum asprosin concentrations were elevated in the post-ERCP pancreatitis group (p < 0,001). Amylase, lipase, GGT, AST, total and direct bilirubin levels also increased significantly in the pancreatitis group. In the pancreatitis group, a negative correlation was observed between asprosin levels and leukocyte (r = -0.433; p = 0.031) and lymphocyte counts (r = -0.440; p = 0.028). No meaningful correlation was observed between asprosin concentrations and the severity of pancreatitis (p = 0,347). Conclusion: In patients with post-ERCP pancreatitis, asprosin levels are increased, which could potentially be associated with the inflammatory response. However, asprosin does not seem to directly reflect disease severity. Therefore, asprosin can be considered as a new biomarker candidate associated with pancreatic beta cell damage and inflammation; however, Additional research is required to elucidate its diagnostic and prognostic role.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 245-257
Post-ERCP Pancreatitis and Serum Asprosin: A Potential Marker Associated with Beta Cell Damage
Aim: Asprosin is a protein produced by adipose tissue that has a significant function in regulating glucose metabolism. Inflammation in pancreatitis leads to beta cell damage and deterioration of beta cell functions. Recent studies have shown a relationship between asprosin and pancreatic beta cell damage. This research aimed to examine the association between pancreatitis developing after endoscopic retrograde cholangiopancreatography (ERCP) and asprosin levels, which is also considered an indicator of beta cell damage. Materials and Methods: The study was conducted with 25 patients who developed pancreatitis after ERCP and 21 participants as a control group at Ankara Bilkent City Hospital. Acute pancreatitis was diagnosed through correlation of clinical, imaging, and laboratory findings. In addition, the post-ERCP pancreatitis group was classified as “mild” and “moderate-severe” according to disease severity, and asprosin levels were compared between the groups. Correlations between asprosin and biochemical and hematological parameters were analyzed. Results: Serum asprosin concentrations were elevated in the post-ERCP pancreatitis group (p < 0,001). Amylase, lipase, GGT, AST, total and direct bilirubin levels also increased significantly in the pancreatitis group. In the pancreatitis group, a negative correlation was observed between asprosin levels and leukocyte (r = -0.433; p = 0.031) and lymphocyte counts (r = -0.440; p = 0.028). No meaningful correlation was observed between asprosin concentrations and the severity of pancreatitis (p = 0,347). Conclusion: In patients with post-ERCP pancreatitis, asprosin levels are increased, which could potentially be associated with the inflammatory response. However, asprosin does not seem to directly reflect disease severity. Therefore, asprosin can be considered as a new biomarker candidate associated with pancreatic beta cell damage and inflammation; however, Additional research is required to elucidate its diagnostic and prognostic role.
- Open Access
- 23 September 2025
- Published by MediHealth Academy in Intercontinental Journal of Emergency Medicine
- Vol. 3 (3) , 52-57
FGF-21 as a potential biomarker for coronary artery calcification: a non-invasive approach
Aims: The aim of this study was to investigate the relationship between fibroblast growth factor 21 (FGF-21) levels and coronary artery calcium (CAC) scores calculated using the Agatston method, and to evaluate the potential of FGF-21 as a non-invasive biomarker for the assessment of coronary artery calcification. Methods: A total of 54 adult individuals who had undergone coronary CT angiography within the past three months solely for cardiovascular risk assessment were prospectively included in the study. Serum FGF-21 levels were measured using the ELISA method, and CAC scores were determined via the Agatston scoring system. The relationship between FGF-21 levels and CAC scores was analyzed using Spearman’s correlation test. Results: A significant and strong positive correlation was observed between FGF-21 levels and CAC scores (r = 0.725, p < 0.001). Diabetes mellitus and hyperlipidemia were significantly associated with higher CAC scores (p = 0.006 and p = 0.024, respectively), whereas their associations with FGF-21 levels were not statistically significant (p = 0.065 and p = 0.104). No significant correlations were found between FGF-21 levels and other variables such as age, gender, hypertension, or biochemical parameters. Conclusion: The findings suggest that serum FGF-21 levels may be associated with coronary artery calcification and could serve as a non-invasive and easily applicable biomarker in individuals for coronary artery disease. FGF-21 may be particularly useful in clinical settings where access to advanced imaging modalities is limited.
- 23 September 2025
- Published by MediHealth Academy in Intercontinental Journal of Emergency Medicine
- Vol. 3 (3) , 52-57
Open AccessFGF-21 as a potential biomarker for coronary artery calcification: a non-invasive approach
Aims: The aim of this study was to investigate the relationship between fibroblast growth factor 21 (FGF-21) levels and coronary artery calcium (CAC) scores calculated using the Agatston method, and to evaluate the potential of FGF-21 as a non-invasive biomarker for the assessment of coronary artery calcification. Methods: A total of 54 adult individuals who had undergone coronary CT angiography within the past three months solely for cardiovascular risk assessment were prospectively included in the study. Serum FGF-21 levels were measured using the ELISA method, and CAC scores were determined via the Agatston scoring system. The relationship between FGF-21 levels and CAC scores was analyzed using Spearman’s correlation test. Results: A significant and strong positive correlation was observed between FGF-21 levels and CAC scores (r = 0.725, p < 0.001). Diabetes mellitus and hyperlipidemia were significantly associated with higher CAC scores (p = 0.006 and p = 0.024, respectively), whereas their associations with FGF-21 levels were not statistically significant (p = 0.065 and p = 0.104). No significant correlations were found between FGF-21 levels and other variables such as age, gender, hypertension, or biochemical parameters. Conclusion: The findings suggest that serum FGF-21 levels may be associated with coronary artery calcification and could serve as a non-invasive and easily applicable biomarker in individuals for coronary artery disease. FGF-21 may be particularly useful in clinical settings where access to advanced imaging modalities is limited.
- Open Access
- 15 June 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (6) , 253
Increased Frequency of the Non-Dipper Blood Pressure Pattern in Patients with Systemic Sclerosis: Insights from 24-Hour Ambulatory Monitoring
Background: In systemic sclerosis (SSc), endothelial dysfunction, inflammation, and reduced nitric oxide levels may disrupt circadian blood pressure (BP) regulation. There are studies showing that inflammatory and certain other cells in diseases like SSc exhibit diurnal rhythms. In our study, we examined the effect of SSc on BP. In particular, the frequency of the non-dipper pattern (lack of nighttime BP reduction) in SSc patients has not been adequately investigated. The aim of this study was to evaluate the 24 h BP profile in SSc patients and to compare the frequency of the non-dipper pattern with that of the non-scleroderma group. Additionally, the identification of disrupted circadian BP patterns in SSc patients aims to contribute to the development of personalized, time-sensitive BP monitoring strategies in the future and to support the applicability of personalized medicine in this context. Methods: A total of 31 SSc patients diagnosed according to the 2013 ACR/EULAR classification criteria and 30 age- and sex-matched individuals without SSc were included in this prospective study. BP changes between day and night were evaluated by measuring BP every 30 min with a 24 h ambulatory blood pressure monitoring (ABPM) device. The non-dipper pattern was defined as a decrease in BP of less than 10% during the night compared to the day. To better assess BP fluctuations during the night, nighttime measurements were divided into two time periods: first, 24:00–04:00, and then 04:00–08:00. Additionally, laboratory and clinical parameters and SSc subtypes were compared between the groups. Results: The ABPM findings were compared between the groups with and without SSc. The non-dipper pattern was significantly more common in the SSc group at all time intervals. The non-dipper pattern was observed in 25.8% of the non-SSc group and 83.9% of SSc patients (p < 0.001). In the period between 24:00 and 04:00, the prevalence was 25.8% in the control group and 71.0% in SSc patients (p < 0.001), and between 04:00 and 08:00, it was 35.5% in the control group and 80.6% in SSc patients (p < 0.001). No significant difference was found in non-dipper patterns between individuals with diffuse and limited cutaneous forms of systemic sclerosis. Conclusions: The non-dipper BP pattern is significantly more common in patients with SSc, indicating the disruption of the circadian rhythm affecting BP. Analysis performed by dividing the night into specific time periods revealed that this deterioration continued throughout the night. The findings highlight the importance of circadian BP monitoring in SSc patients and may contribute to future risk stratification and treatment strategies. Circadian BP analysis in SSc may help to develop strategies that are personalized for these patients and tailored to their physiological rhythm.
- 15 June 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (6) , 253
Open AccessIncreased Frequency of the Non-Dipper Blood Pressure Pattern in Patients with Systemic Sclerosis: Insights from 24-Hour Ambulatory Monitoring
Background: In systemic sclerosis (SSc), endothelial dysfunction, inflammation, and reduced nitric oxide levels may disrupt circadian blood pressure (BP) regulation. There are studies showing that inflammatory and certain other cells in diseases like SSc exhibit diurnal rhythms. In our study, we examined the effect of SSc on BP. In particular, the frequency of the non-dipper pattern (lack of nighttime BP reduction) in SSc patients has not been adequately investigated. The aim of this study was to evaluate the 24 h BP profile in SSc patients and to compare the frequency of the non-dipper pattern with that of the non-scleroderma group. Additionally, the identification of disrupted circadian BP patterns in SSc patients aims to contribute to the development of personalized, time-sensitive BP monitoring strategies in the future and to support the applicability of personalized medicine in this context. Methods: A total of 31 SSc patients diagnosed according to the 2013 ACR/EULAR classification criteria and 30 age- and sex-matched individuals without SSc were included in this prospective study. BP changes between day and night were evaluated by measuring BP every 30 min with a 24 h ambulatory blood pressure monitoring (ABPM) device. The non-dipper pattern was defined as a decrease in BP of less than 10% during the night compared to the day. To better assess BP fluctuations during the night, nighttime measurements were divided into two time periods: first, 24:00–04:00, and then 04:00–08:00. Additionally, laboratory and clinical parameters and SSc subtypes were compared between the groups. Results: The ABPM findings were compared between the groups with and without SSc. The non-dipper pattern was significantly more common in the SSc group at all time intervals. The non-dipper pattern was observed in 25.8% of the non-SSc group and 83.9% of SSc patients (p < 0.001). In the period between 24:00 and 04:00, the prevalence was 25.8% in the control group and 71.0% in SSc patients (p < 0.001), and between 04:00 and 08:00, it was 35.5% in the control group and 80.6% in SSc patients (p < 0.001). No significant difference was found in non-dipper patterns between individuals with diffuse and limited cutaneous forms of systemic sclerosis. Conclusions: The non-dipper BP pattern is significantly more common in patients with SSc, indicating the disruption of the circadian rhythm affecting BP. Analysis performed by dividing the night into specific time periods revealed that this deterioration continued throughout the night. The findings highlight the importance of circadian BP monitoring in SSc patients and may contribute to future risk stratification and treatment strategies. Circadian BP analysis in SSc may help to develop strategies that are personalized for these patients and tailored to their physiological rhythm.
- 25 March 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (6) , 2186-2193
A New Simple Scoring System for Early Prediction of Severe Acute Pancreatitis
Background/Objectives Acute pancreatitis (AP) is an inflammatory condition with rising incidence, often resulting in severe complications and increased mortality, particularly when accompanied by organ failure. Early identification of patients at risk for severe AP is essential for timely intervention. Current scoring systems like Ranson’s, BISAP, and APACHE-II, though useful, have limitations in terms of time and specificity. We aimed to identify a simple and early scoring system to predict severe AP. Methods In this single-center study conducted over two years, patients diagnosed with AP within 72 h of symptom onset were enrolled. Initial clinical and laboratory data were prospectively collected according to established criteria, including BISAP, APACHE-II, and Ranson’s. Multivariate logistic regression analyses were performed to identify independent risk factors for severe AP, which were then used to develop a new scoring system. Results In our population of 424 patients (8.5% severe), we identified key clinical and laboratory markers—blood urea nitrogen (BUN), neutrophil-to-lymphocyte ratio (NLR), and heart rate—as independent predictors of severe AP. Based on these factors, we developed the BHN scoring system, which demonstrated non-inferior sensitivity (91.7%) and specificity (83.3%) for predicting severe disease, compared to more complex systems BISAP, Ranson’s, and APACHE-II. Conclusion The BHN score offers a simple, accessible tool in a variety of clinical settings, improving early risk stratification. External validation and further exploration of its use in mortality prediction are needed, but BHN presents a promising alternative for guiding early treatment decisions in acute pancreatitis.
- 25 March 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (6) , 2186-2193
A New Simple Scoring System for Early Prediction of Severe Acute Pancreatitis
Background/Objectives Acute pancreatitis (AP) is an inflammatory condition with rising incidence, often resulting in severe complications and increased mortality, particularly when accompanied by organ failure. Early identification of patients at risk for severe AP is essential for timely intervention. Current scoring systems like Ranson’s, BISAP, and APACHE-II, though useful, have limitations in terms of time and specificity. We aimed to identify a simple and early scoring system to predict severe AP. Methods In this single-center study conducted over two years, patients diagnosed with AP within 72 h of symptom onset were enrolled. Initial clinical and laboratory data were prospectively collected according to established criteria, including BISAP, APACHE-II, and Ranson’s. Multivariate logistic regression analyses were performed to identify independent risk factors for severe AP, which were then used to develop a new scoring system. Results In our population of 424 patients (8.5% severe), we identified key clinical and laboratory markers—blood urea nitrogen (BUN), neutrophil-to-lymphocyte ratio (NLR), and heart rate—as independent predictors of severe AP. Based on these factors, we developed the BHN scoring system, which demonstrated non-inferior sensitivity (91.7%) and specificity (83.3%) for predicting severe disease, compared to more complex systems BISAP, Ranson’s, and APACHE-II. Conclusion The BHN score offers a simple, accessible tool in a variety of clinical settings, improving early risk stratification. External validation and further exploration of its use in mortality prediction are needed, but BHN presents a promising alternative for guiding early treatment decisions in acute pancreatitis.
- Open Access
- 25 January 2024
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
A CASE OF SARCOIDOSIS WITH ATYPICAL PRESENTATION
Sarcoidosis is a multisystem disease of unknown etiology, characterized by noncaseating granulomas. While lung findings present in 90% of the cases, extrapulmonary sarcoidosis cases are very rare and useally hard to diagnose due to the atypical clinical course. Here, we aimed to present a case of extrapulmonary sarcoidosis diagnosed after exclusion of MAS and lymphoma during clinical follow-up.
- 25 January 2024
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
Open AccessA CASE OF SARCOIDOSIS WITH ATYPICAL PRESENTATION
Sarcoidosis is a multisystem disease of unknown etiology, characterized by noncaseating granulomas. While lung findings present in 90% of the cases, extrapulmonary sarcoidosis cases are very rare and useally hard to diagnose due to the atypical clinical course. Here, we aimed to present a case of extrapulmonary sarcoidosis diagnosed after exclusion of MAS and lymphoma during clinical follow-up.